NIPH Clinical Trials Search

UMIN ID: UMIN000049648

Registered date:01/12/2023

Validation of Fugl-Meyer assessment

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedstroke
Date of first enrollment2023/11/01
Target sample size10
Countries of recruitmentJapan
Study typeObservational


Primary OutcomeThe Japanese version of the FMA will be evaluated in patients 180 days after the onset of cerebral infarction or hemorrhage. Two examiners will evaluate one patient on two separate days.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteria1) Patients with a score of less than 23 on the Mini Mental State Examination-Japanese, 2) Patients with amputation of any limb, 3) Patients with aphasia or psychiatric disorders that affect daily life, 4) Patients with severe joint pain that makes participation in the study difficult, 5) Patients with visual or hearing impairment, 6) Patients with serious terminal symptoms or uncontrolled medical conditions that would preclude their participation.

Related Information


public contact
Name Yukitaka Tomdoa
Address 1788, Kusakabe, Doujo, Kita ward, Kobe sity Japan 651-1505
Telephone 078-950-2622
Affiliation Kosei Hospital Rehabilitation Department
scientific contact
Name Toru Nagao
Address 7-10-2, Tomogaoka, Suma ward, Kobe city Japan
Telephone 078-792-2555
Affiliation Kobe University Graduate School Healt Science